Postmarket Reviews - Volume 2, Number 2, 2009

Postmarket Reviews - Volume 2, Number 2, 2009
Back to Table of Contents

- Quinine Sulfate (Marketed as Qualaquin): Off-Label (Not Approved by FDA) Use of Quininess
-- Zolendronic Acid (Marketed as Reclast): Renal Impairment and Acute Liver Failure
--- Arginine Hydrochloride Injection (Marketed as R-Gene 10): Fatal Medication Errors in a Pediatric Population

abrir aquí para acceder a los documentos (idioma inglés únicamente):
Postmarket Reviews - Volume 2, Number 2, 2009